To study early stages in embryonic development in the cell culture dish, scientists use so-called human pluripotent stem […]

Get a structured handoverArafat Mulla, specialty trainee year 4 in respiratory medicine, North West deanery, says, “Be in […]

Accelerate@Babraham supports early-stage life sciences ventures within the Babraham Research Campus’ community

CureVac’s CVnCoV is currently being investigated in a randomised, placebo-controlled Phase IIb/III clinical trial

CDK4 & 6 inhibitor has been available as part of a Cancer Drugs Fund (CDF) managed access agreement

People aged 65 to 69 and the clinically vulnerable will be offered the jab from today

Patients with advanced kidney cancer, who received a targeted drug combined with a checkpoint-blocker immunotherapy agent had longer […]

A new research paper reveals a potential revolutionary drug combination that could become an effective treatment for the […]

Ebola is so pernicious because it pulls a fast one on the body, disguising itself as a dying […]